- Home
- NLSP vs TLS Comparison
NLSP vs TLS Comparison
Compare NLSP & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- TLS
- Stock Information
- Founded
- NLSP 2015
- TLS 1969
- Country
- NLSP Switzerland
- TLS United States
- Employees
- NLSP N/A
- TLS N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- TLS EDP Services
- Sector
- NLSP Health Care
- TLS Technology
- Exchange
- NLSP Nasdaq
- TLS Nasdaq
- Market Cap
- NLSP 12.4M
- TLS 199.9M
- IPO Year
- NLSP 2021
- TLS 2020
- Fundamental
- Price
- NLSP $2.10
- TLS $2.75
- Analyst Decision
- NLSP
- TLS Buy
- Analyst Count
- NLSP 0
- TLS 6
- Target Price
- NLSP N/A
- TLS $3.94
- AVG Volume (30 Days)
- NLSP 275.3K
- TLS 974.0K
- Earning Date
- NLSP 07-22-2025
- TLS 08-08-2025
- Dividend Yield
- NLSP N/A
- TLS N/A
- EPS Growth
- NLSP N/A
- TLS N/A
- EPS
- NLSP N/A
- TLS N/A
- Revenue
- NLSP N/A
- TLS $109,269,000.00
- Revenue This Year
- NLSP N/A
- TLS $35.76
- Revenue Next Year
- NLSP N/A
- TLS $26.83
- P/E Ratio
- NLSP N/A
- TLS N/A
- Revenue Growth
- NLSP N/A
- TLS N/A
- 52 Week Low
- NLSP $1.30
- TLS $1.83
- 52 Week High
- NLSP $15.59
- TLS $4.82
- Technical
- Relative Strength Index (RSI)
- NLSP 46.61
- TLS 45.47
- Support Level
- NLSP $2.20
- TLS $3.01
- Resistance Level
- NLSP $3.08
- TLS $3.30
- Average True Range (ATR)
- NLSP 0.25
- TLS 0.21
- MACD
- NLSP -0.06
- TLS -0.02
- Stochastic Oscillator
- NLSP 8.40
- TLS 40.86
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.